305 related articles for article (PubMed ID: 27888613)
1. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.
Song M; Wang Y; Zhang Z; Wang S
Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613
[TBL] [Abstract][Full Text] [Related]
2. Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.
He J; Xing J; Yang X; Zhang C; Zhang Y; Wang H; Xu X; Wang H; Cao Y; Xu H; Zhang C; Wang C; Yu E
Chemotherapy; 2019; 64(3):146-154. PubMed ID: 31715603
[TBL] [Abstract][Full Text] [Related]
3. Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation, migration and invasion by targeting PSMC2.
Li GW; Yan X
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1915-1925. PubMed ID: 30915734
[TBL] [Abstract][Full Text] [Related]
4. PSMC2/CCND1 axis promotes development of ovarian cancer through regulating cell growth, apoptosis and migration.
Zhu D; Huang J; Liu N; Li W; Yan L
Cell Death Dis; 2021 Jul; 12(8):730. PubMed ID: 34294689
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1.
Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
Aging (Albany NY); 2021 Sep; 13(17):21325-21344. PubMed ID: 34499615
[TBL] [Abstract][Full Text] [Related]
6. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU).
Wang Y; Zhu M; Li J; Xiong Y; Wang J; Jing H; Gu Y
Cell Death Dis; 2021 Jul; 12(7):690. PubMed ID: 34244472
[TBL] [Abstract][Full Text] [Related]
8. The effect of DNA-PKcs gene silencing on proliferation, migration, invasion and apoptosis, and in vivo tumorigenicity of human osteosarcoma MG-63 cells.
Jin PY; Lu HJ; Tang Y; Fan SH; Zhang ZF; Wang Y; Li XN; Wu DM; Lu J; Zheng YL
Biomed Pharmacother; 2017 Dec; 96():1324-1334. PubMed ID: 29203385
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
Chen Y; Huang T; Yang X; Liu C; Li P; Wang Z; Zhi S
Oncol Rep; 2018 Oct; 40(4):2251-2259. PubMed ID: 30066949
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
[TBL] [Abstract][Full Text] [Related]
11. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
[TBL] [Abstract][Full Text] [Related]
12. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
13. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
14. PSMC2 knockdown exerts an anti-tumor role in nasopharyngeal carcinoma through regulating AKT signaling pathway.
Su J; Hu S; Ding S; Feng K
Cell Cycle; 2023 Nov; 22(21-22):2381-2391. PubMed ID: 38123344
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells.
Ruan W; Wang P; Feng S; Xue Y; Li Y
Tumour Biol; 2016 Mar; 37(3):4065-73. PubMed ID: 26486328
[TBL] [Abstract][Full Text] [Related]
16. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
Yuan Q; Yu H; Chen J; Song X; Sun L
Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
[TBL] [Abstract][Full Text] [Related]
18. PSMC2 is overexpressed in glioma and promotes proliferation and anti-apoptosis of glioma cells.
Zheng X; Wang Y; Wang D; Wan J; Qin X; Mu Z; Hu N
World J Surg Oncol; 2022 Mar; 20(1):84. PubMed ID: 35287689
[TBL] [Abstract][Full Text] [Related]
19. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
[TBL] [Abstract][Full Text] [Related]
20. Silencing of Kv1.5 Gene Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells.
Wu J; Chen Z; Liu Q; Zeng W; Wu X; Lin B
Int J Mol Sci; 2015 Nov; 16(11):26914-26. PubMed ID: 26569226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
